Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma-Reference-Cited by-同舟云学术

Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma

Published:2003-11 Issue:5 Volume:197 Page:759-764
ISSN:1072-7515
Container-title:Journal of the American College of Surgeons
language:en
Short-container-title:Journal of the American College of Surgeons

Author:

Harrison Lawrence E,Koneru Baburao,Baramipour Phil,Fisher Adrian,Barone Alison,Wilson Dorian,Dela Torre Andrew,Cho Kyunghee C,Contractor Daniel,Korogodsky Maria

Publisher

Elsevier BV

Subject

Surgery

Reference18 articles.

1. Rising incidence of hepatocellular carcinoma in the United States;El Serag;N Engl J Med,1999

2. Epidemiology of primary liver cancer;Bosch;Semin Liver Dis,2002

3. Increase in primary liver cancer in the UK, 1979–94;Taylor-Robinson;Lancet,1997

4. Improving survival results after resection of hepatocellular carcinoma;Poon;Ann Sug,2001

5. Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C;Roayaie;Ann Surg Oncol,2000

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term results of liver thermal ablation in patients with hepatocellular carcinoma and colorectal cancer liver metastasis regarding spatial features and tumor-specific variables;Diagnostic and Interventional Radiology;2023-04-01

2. Gadoxetic acid–enhanced MRI with a focus on LI-RADS v2018 imaging features predicts the prognosis after radiofrequency ablation in small hepatocellular carcinoma;Frontiers in Oncology;2023-02-02

3. Application and Evaluation of a 64-Slice CT Three-Dimensional Fusion Technique in the Determination of the Effective Ablation Margin after Radiofrequency Ablation of Hepatocellular Carcinoma;Computational and Mathematical Methods in Medicine;2022-01-27

4. Iodine-125 Brachytherapy Can Prolong Progression-Free Survival of Patients with Locoregional Recurrence and/or Residual Hepatocellular Carcinoma After Radiofrequency Ablation;Cancer Biotherapy and Radiopharmaceuticals;2021-12-01

5. Outcomes After Stereotactic Body Radiation Therapy as a Bridging Modality to Liver Transplantation for Hepatocellular Carcinoma;Advances in Radiation Oncology;2021-01